Thr-Leu pairs polar threonine with hydrophobic leucine to model early-stage folding behaviors. The dipeptide enables detailed examination of hydrogen bonding and amphipathic tendencies. Researchers explore its solution dynamics and enzymatic recognition patterns. Applications include structural modeling, motif analysis, and peptide-synthesis refinement.
CAT No: R2664
CAS No:50299-12-2
Synonyms/Alias:H-Thr-Leu-OH;Thr-Leu;50299-12-2;L-threonyl-L-leucine;threonylleucine;CHEBI:74860;(2S)-2-[[(2S,3R)-2-amino-3-hydroxybutanoyl]amino]-4-methylpentanoic acid;(S)-2-((2S,3R)-2-Amino-3-hydroxybutanamido)-4-methylpentanoic acid;Threoninylleucine;Threonyl-leucine;TL dipeptide;T-L Dipeptide;Threoninyl-Leucine;H-Thr-Leu;MFCD00083825;L-Thr-L-Leu;L-Threoninyl-L-Leucine;Threonine Leucine dipeptide;Threonine-Leucine dipeptide;CHEMBL1221899;SCHEMBL14842720;BQBCIBCLXBKYHW-CSMHCCOUSA-N;AS-82914;FT108186;CS-0453119;G77914;Q27144970;(2S)-2-[(2S,3R)-2-AMINO-3-HYDROXYBUTANAMIDO]-4-METHYLPENTANOIC ACID;
Thr-Leu, also known as Threonylleucine, is a dipeptide composed of the amino acids threonine and leucine linked by a peptide bond. As a naturally occurring peptide fragment, Thr-Leu is recognized for its distinctive physicochemical properties, including hydrophilicity and moderate stability under physiological conditions. Its structure enables it to participate in various biochemical processes, making it a valuable tool in peptide research, analytical chemistry, and the development of novel biomaterials. The presence of both a polar side chain (from threonine) and a hydrophobic side chain (from leucine) allows Thr-Leu to interact with diverse biological molecules, facilitating its integration into complex experimental systems. Researchers often utilize Thr-Leu as a model compound to investigate peptide behavior, enzymatic hydrolysis, and structure-activity relationships in oligopeptides.
Peptide Mapping and Proteomics: In proteomics research, Thr-Leu serves as a reference dipeptide for optimizing chromatographic separation and mass spectrometric detection techniques. Its defined chemical composition and fragmentation patterns are particularly useful for calibrating instruments and validating analytical methods. By incorporating Thr-Leu into peptide mapping workflows, scientists can enhance the accuracy and reproducibility of protein identification and quantification, especially when analyzing complex biological samples. The dipeptide's predictable retention time and ionization behavior make it a reliable internal standard for comparative studies, ensuring consistent performance across multiple experimental runs.
Enzyme Substrate Specificity Studies: Thr-Leu is frequently employed as a substrate in enzymology to probe the specificity and catalytic mechanisms of various peptidases and proteases. Its unique sequence, featuring a hydroxyl group on threonine and a bulky hydrophobic residue in leucine, provides insights into the substrate preferences of enzymes involved in peptide bond cleavage. By monitoring the hydrolysis of Thr-Leu under controlled conditions, researchers can elucidate enzyme kinetics, determine substrate affinity, and identify potential inhibitors or activators. This application is critical for advancing our understanding of enzymatic pathways and for screening compounds that modulate protease activity in fundamental research.
Peptide Transport and Absorption Research: The study of peptide transporters in cellular and tissue models often relies on dipeptides like Thr-Leu to investigate uptake mechanisms and transport efficiency. Due to its balanced hydrophilic and hydrophobic characteristics, Thr-Leu is an ideal candidate for assessing the substrate specificity of peptide transporters such as PEPT1 and PEPT2. Experimental data derived from Thr-Leu uptake studies contribute to the broader understanding of nutrient absorption, cellular uptake dynamics, and the design of transporter-targeted delivery systems in pharmaceutical and nutritional sciences.
Biomaterials and Functional Peptide Design: The incorporation of Thr-Leu into synthetic peptides and biomaterials enables the exploration of structure-function relationships and the development of novel functional materials. Its amphiphilic nature allows researchers to design self-assembling peptides, hydrogels, and nanostructures with tunable properties for use in tissue engineering, drug delivery, and biosensing applications. By leveraging the chemical diversity introduced by the threonine and leucine residues, scientists can tailor the physical and biological characteristics of peptide-based materials to meet specific research objectives.
Quality Control and Analytical Method Validation: Analytical laboratories utilize Thr-Leu as a standard for validating quantitative and qualitative methods in peptide analysis. Its well-characterized mass and chromatographic behavior make it suitable for system suitability testing, calibration curve construction, and method development in high-performance liquid chromatography (HPLC) and liquid chromatography-mass spectrometry (LC-MS) platforms. Employing Thr-Leu in quality control protocols ensures the reliability and accuracy of peptide quantification, supporting rigorous experimental workflows and facilitating the advancement of peptide research across diverse scientific disciplines.
1. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
2. Emu oil in combination with other active ingredients for treating skin imperfections
4. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.